Keywords
treatment
diagnosis
Categories
How to Cite
Abstract
Abstract. Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated fibro-inflammatory disorder, characterized by a tissue IgG4(+)plasma cells infiltration, leading to fibrosis and destruction of the involved organs. The IgG4-RD scope includes all organs and systems but within the review only the actual diagnostic and therapeutic data concerning disease localisations in the lacrimal and salivary glands, kidneys, retroperitoneum, lungs and aorta and arteries are included because they are also a terrain of a rheumatological pathology – vasculitides, Sjogren’s syndrome, SLE, systemic sclerosis and so on.
References
Васильев ВИ, Сокол ЕВ, Седышев СХ и др. Дифференциальная диагностика ревматических и онкологических заболеваний, поражающих полость и придаточные пазухи носа. Тер Арх, 2014, 86(5): 62-72.
Васильев ВИ, Сокол ЕB, Родионова ЕБ и др. Связанные с IgG4-поражения слюнных желез. Тер Арх, 2015, 87(8): 92-102.
Симонова ПВ, Васильев ВИ, Корнилова НН и др. Дифференциальная диагностика болезни Микулича и болезни Шегрена. Стоматол, 1988, (3): 71-73.
Сокол EВ, Васильев ВИ. Лечение IgG4-связанного заболевания. Науч Практ Ревматол, 2016, 54(3): 352-360.
Сокол EВ, Васильев ВИ, Польтина СГ и др. Клинико-лабораторная характеристика IgG4-связанного заболевания и алгоритм его диагностики. Тер Арх, 2019, 91(5): 40-48.
Сокол ЕВ. IgG4-связанное заболевание: что мы знаем 20 лет спустя. Тер Арх, 2020, 92(5): 104-109.
Стоилов Н, Бояджиева В, Стоилов Р и др. Болест на Ормонд в ревматологичната практика. Ревматол, 2015, 23(3): 59-71.
Brito-Zeron P, Bosch X, Ramos-Casals M et al. IgG4-related disease: advances in diagnosis and treatment. Pract Res Clin Rheumatol, 2016, 30: 261-278.
Cao Lu, Chen Y-B, Zhao DH et al. Pulmonary function tests findings and their diagnostic value in patients with IgG4-related disease. J Thorax Dis, 2017, 9(3): 547-554.
Carruthers MH, Khosroshahi A, Angastin T et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis, 2015, 74: 14-18.
Carruthers MH, Stone JH, Deshpande V et al. Development of an IgG4-RD responder index. Int J Rheumatol, 2012, doi: 10.1155/2012/254908.
Chen LF, Liang JJ, Ouyang M et al. Application of the 2019 ACR/EULAR classification criteria contributes to the diagnosis of IgG4-related disease. EULAR Congress 2020, AB1020.
Cho YD, Jung WJ, Lee Y et al. Perirenal capsule and scrotal involvement in immunoglobulin G4-related disease: care based review. Rheumatol Intern, 2018, 38(10): 1941-1948.
Cheuck W, Yuen HK, Chen JK et al. Chronic sclerosing dacryoadenitis – part of the spectrum of IgG4-related disease. Am J Surg Pathol, 2006, 31: 643-645.
Deshpande V, Zen Y, Chan KG et al. Consensus statement on the pathology of IgG4. Mod Pathol, 2012, 25: 1181-1192.
Hamano H, Kawa S, Horiuchi A et al. High serum concentrations in patients with sclerosing pancreatitis. N Engl J Med, 2001, 344(10): 732-738.
Hermet M, Andre M, Kemeny JL et al. Is IgG4-related disease a cause of xerostomia? A cohort study of 60 patients. Int J Rheumatol, 2012, Published online Oct 16.
Inoue D, Zen Y, Abo H et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology, 2009, 251(1): 260-270.
Ishikawa Y, Teruo C. Genetic analysis of IgG4-related disease. Mod Rheumatol, 2019, doi: 10.1080/14397595.2019.1621000.
Ito T, Fukui S, Kanie T et al. IgG4-related coronary periarteritis: systemic literature review with our case series. EULAR Congress 2021, AB0763.
Jansen I, Hendrics TR, Han SH et al. 18F-fluorodeoxyglucose positron tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med, 2010, 21: 216-221.
Kamisawa T, Funata N, Hayashi Y et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol, 2003, 38: 982-984.
Kamisawa T, Zen Y, Pillai P et al. IgG4-related disease. Lancet, 2015, 385: 1460-1471.
Kawano M, Saeki T, Nakashima H. IgG4-kidney disease and retroperitoneal fibrosis: an update. Mod Rheumatol, 2018, 29(2): 231-239.
Kawano M, Saeki T, Nakashima H et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol, 2011, 15(5): 615-626.
Khosroshahi A, Carruthers MH, Stone JH et al. Rethinking Ormond’s disease: “idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore), 2013, 92: 82-91.
Khosroshahi A, Wallace ZS, Crowe JL et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheum, 2015, 67: 1688-1699.
Kurowecki D, Patlas MN, Heider A et al. Cross-sectional pictorial review of IgG4-related disease. Br J Radiol, 2019, 92: 448-453.
Lanzillotta M, Della Torre E, Campochiaro C et al. Clinical phenotypes of IgG4-related disease reflects differences in epidemiological features, serological findings and prognostic outcomes. EULAR Congress 2020, suppl.1, SAT0528.
Li ZY, Wang X, Xia X et al. An overlap of antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis and IgG4-related kidney disease. Clin Chim Acta, 2020, 501: 12-19.
Liu SB, Gao H, Feng YC et al. Clinical features of hydronephrosis induced by retroperitoneal fibrosis: 17 cases reported. J Peking Univ Health Sci, 2020, 52(6): 1069-1074.
Liu Y, Xue M, Wang Zh et al. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients. Rheumatology, 2020, 59: 634-640.
Masaki Y, Dong L, Kurose N et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis, 2009, 68: 1310-1315.
Matsui S, Yamamoto H, Minamoto S et al. Proposed diagnostic criteria for IgG4-related respiratory disease. Respir Invest, 2016, 54: 130-132.
Matsui S. IgG4-respiratory disease. Mod Rheumatol, 2019, 29(2): 251-256.
Miyabe K, Zen Y, Connall LD et al. Gastrointestinal and extra-intestinal manifestations of IgG4-related disease. Gastroenterology, 2018, 155: 990-1003.
Mizushima I, Yamada K, Fujii H et al. Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis. Mod Rheumatol, 2012, 22: 859-870.
Mizushima I, Yamamoto M, Inoue D et al. Factors related to renal cortical atrophy development after glucocorticoid therapy in IgG4-related kidney disease: a retrospective multicenter study. Arthr Res Ther, 2016, 18: 273-281.
Morales AT, Cignarella AG, Safayeth Yabeen I et al. An update on IgG4-related lung disease. Eur J Int Med, 2019, 66: 18-24.
Morgan WG, Castleman B. A clinicopathologic study of Mikulicz’s disease. Am J Pathol, 1953, 29: 471-503.
Moriyama M, Furukawa S, Kawano Y et al. The diagnostic utility of biopsies from submandibular and labial salivary glands in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz’s disease. Int J Oral Maxillofac Surg, 2018, 43: 12-80.
Murata Y, Aoe K, Mimura I. Pleural effusion related to IgG4. Curr Opin Pulm Med, 2019, 25(4): 384-389.
Oyama-Manabe N, Yabusaki S, Manabe D et al. IgG4-related cardiovascular disease from the aorta to the coronary arteritis: multidetector CT and PET/CT. Radiographics, 2018, 38: 1934-1948.
Palmisano A, Maritati F, Vaglio A. Chronic periaortitis. Curr Rheum Rep, 2018, 20(12): 80.
Perugino CA, Wallace ZS, Meyersohn N et al. Large vessel involvement in IgG4-related disease. Medicine, 2016, 95: 28-40.
Raissian Y, Nasr SH, Larsen CP et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol, 2011, 22: 1343-1352.
Ryu JH, Sekiguchi H, Yi ES. Pulmonary manifestations of Immunoglobulin G4-related sclerosing disease. Eur Respir J, 2012, 39: 180-186.
Saeki T, Kawano M, Mizushima I et al. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Clin Exp Nephrol, 2016, 20: 87-93.
Saeki T, Kawano M, Nagasawa T et al. Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011 and proposal of a new 2020 version. Clin Exp Nephrol, 2021, 25: 99-109.
Saunders S, Della-Torre E, Perugino CA et al. Salivary gland disease in IgG4-related disease associated with allergic histories. Arthritis Rheum, 2018, 70, suppl.
Shrestha B, Sekiguchi M, Colby T et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis. Report of 6 and 12 cases with similar histopathology. Am J Surg Pathol, 2009, 33: 1450-1462.
Stone JH, Khosroshahi A, Deshpande V et al. IgG4-related disease: recommendations for the nomenclature of this condition and its individual organ system manifestations. Arthritis Rheum, 2012, 64(10): 3061-3067.
Sun H, Lin H, Feng R et al. Biopsy proven IgG4-related lung disease. BMC Pulm Med, 2016, 16: 20-26.
Tsushima T, Tanaka T, Kazuki T et al. Pulmonary involvement of autoimmune pancreatitis. Eur Clin Invest, 2009, 39(8): 714-722.
Umehara H, Okazaki K, Masaki Y et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD) 2011. Mod Rheumatol, 2012, 22: 21-30.
Umehara H, Okazaki K, Nakamura T et al. Current approach to IgG4-related disease – combination of comprehensive diagnostic and organ specific criteria. Mod Rheumatol, 2017, 27(3): 381-391.
Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet, 2006, 367: 241-251.
Vaglio A, Palmisano A, Alberici F et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomized controlled trial. Lancet, 2011, 378: 338-346.
Vaglio A, Maritati F. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol, 2016, 21: 1880-1889.
Wallace ZS, Deshpande V, Mattoo N et al. IgG4-related disease: baseline clinical and laboratory features in 125 patients with biopsy proven disease. Arthritis Rheum, 2015, 67(9): 2466-2475.
Wallace ZS, Naden RP, Chari S et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheum, 2019, 71: 1-13.
Wallace ZS, Zhang Y, Perugino A et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis, 2019, 78(3): 406-412.
Zhang Z, Jiaxi L, Liu Y et al. Different clinical characteristics of IgG4-RD patients and non-IgG4-RD patients: a large Chinese cohort study. EULAR Congress 2021, POS1384.
Wang O, Zhao N, Wang X et al. Renal pseudotumor: a new challenge in the diagnosis of immunoglobulin G4-related disease. J Cancer Res Ther, 2020, 16: 148-153.
Xu WL. Diagnostic performance of serum IgG4-level for IgG4-related disease: a meta-analysis. Sci Rep, 2016, 6: 22035.
Yamada K, Yamamoto M, Saeki T et al. Study of basal clinical features of 324 cases. Arthritis Res Ther, 2017, 19(1): 262.
Yamamoto M, Harada S, Ohara M et al. Clinical and pathological differences between Mikulicz’s disease and Sjogren’s syndrome. Rheumatology, 2005, 44: 227-234.
Zen Y, Kitagawa S, Minato H et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Human Pathol, 2005, 36: 710-717.
Zen Y, Onodera M, Inoue D et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol, 2009, 33: 1833-1839.
Zen Y. Pathological characteristics and diagnosis of IgG4-related disease. Presse Med, 2020, 49: 104-114.
Zhang J, Chan M, Ma J et al. Characterizing IgG4-related disease with FDG PET/CT: a prospective cohort study. J Nucl Med Mol Imaging, 2014, 41: 1624-1634.
Zhang P, Yin Q, Wang W et al. Clinicopathological features of IgG4-related kidney disease (IgG4RKD) in Chinese patients. Clin Nephrol, 2020, 94(3): 135-144.
Choi SJ, Nam H, Lee JS et al. Treatment response of hydronephrosis associated with idiopathic retroperitoneal fibrosis, focussing on ratio of IgG4/IgG3 serum concentration. EULAR Congress 2021, AB1018.
This work is licensed under a Creative Commons Attribution 4.0 International License.